drugset / Trial / NCT00635141

The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis

NCT00635141 ↗

RandomizedCrossoverTriple-blindTreatment

Summary

This study is examining the effect of hypertonic saline compared to placebo on the Lung Clearance Index in Cystic Fibrosis patients.

Timeline

Start
2008-03
Primary completion
2008-12
Completion
2008-12

Outcome

Met primary endpoint

paper Four weeks of twice-daily HS inhalation significantly improved the LCI compared with IS (1.16, 95% CI 0.26 to 2.05; p=0.016) PMID 20435858 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 7 % Inhaled

Indications